Aanesthetic Agents for Day Surgery - NIHR Health Technology ...
Aanesthetic Agents for Day Surgery - NIHR Health Technology ...
Aanesthetic Agents for Day Surgery - NIHR Health Technology ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
The structure and content of this discussion<br />
follows the revised Consolidated Standards<br />
<strong>for</strong> Reporting of Trials (CONSORT) statement<br />
<strong>for</strong> reporting randomised trials. 262<br />
The overall aim of the CESA project was to assess<br />
the relative cost-effectiveness of different anaesthetic<br />
agents in adult and paediatric day surgery.<br />
The rationale <strong>for</strong> this was a perceived need to<br />
provide the NHS with new and reliable in<strong>for</strong>mation<br />
about the relative value <strong>for</strong> money of<br />
alternative methods of anaesthesia. The CESA<br />
project is based on the premise that that there are<br />
no differences in the long-term clinical outcomes,<br />
such as death, respiratory and cardiac sequelae or<br />
long-term cognitive differences, associated with the<br />
use of different anaesthetic agents and techniques.<br />
The optimal choice of anaesthetic agent <strong>for</strong> daysurgery<br />
anaesthesia depends on the profile of<br />
short-term, transient effects, patient preferences<br />
and the costs of the alternatives.<br />
The CESA project comprised three interrelated<br />
studies to assess these short-term clinical, patient<br />
and cost outcomes. The first of these studies was a<br />
literature review of the clinical, patient outcome<br />
and economic literature to assess the evidence<br />
currently available. Secondly, a survey of current<br />
practice in anaesthesia <strong>for</strong> day surgery was undertaken.<br />
Both the literature review and the national<br />
survey were used to in<strong>for</strong>m the design of an RCT<br />
of alternative anaesthetic agents, which was the<br />
third component of the project (CESA RCT).<br />
This chapter summarises the findings of each of<br />
these components of the CESA project. Practical<br />
problems encountered in the implementation of<br />
the CESA RCT are presented, followed by a<br />
discussion of the internal and external validity<br />
of the CESA RCT. Finally, key conclusions are<br />
drawn <strong>for</strong> health policy, clinical practice and<br />
the need <strong>for</strong> future research.<br />
Findings of the study<br />
Literature review<br />
The literature review of clinical papers identified<br />
a large number of high-quality RCTs (grade I) of<br />
methods of anaesthesia and anaesthetic agents used<br />
in adult and paediatric day surgery. However, the<br />
© Queen’s Printer and Controller of HMSO 2002. All rights reserved.<br />
Chapter 7<br />
Discussion<br />
<strong>Health</strong> <strong>Technology</strong> Assessment 2002; Vol. 6: No. 30<br />
comparability of the studies was low, owing<br />
to a wide variation in the patient groups, anaesthetic<br />
agents and treatment protocols, surgical<br />
procedures and primary clinical outcomes used.<br />
PONV was the most commonly used measure,<br />
but varied in how and when it was measured.<br />
There<strong>for</strong>e, few firm conclusions could be drawn<br />
about the relative effectiveness of frequently used<br />
alternative agents. The review of patient-based<br />
outcomes identified mainly descriptive studies,<br />
with very few comparative evaluations. The review<br />
of the cost and economic literature yielded a<br />
small number of low-quality evaluations.<br />
The overall findings of the literature review<br />
were that:<br />
• the available evidence on short-term outcomes<br />
concentrated on predischarge PONV and<br />
discharge times<br />
• there was no clinical, patient-based outcome<br />
or economic evidence to indicate the optimal<br />
agent <strong>for</strong> anaesthesia in day surgery<br />
• there was no clinical, patient-based outcome<br />
or economic evidence to indicate the optimal<br />
method of induction (inhalational or<br />
intravenous) anaesthesia in day surgery<br />
• TIVA is not yet standard practice in anaesthesia<br />
<strong>for</strong> day surgery in paediatric patients<br />
• desflurane is not used in British practice and<br />
is not an appropriate comparator<br />
• the tools used to measure outcomes were<br />
varied and mostly unvalidated<br />
• patients may not consider PONV, mode of<br />
anaesthesia or cognitive function to be<br />
important outcomes.<br />
National survey of anaesthetic practice<br />
<strong>for</strong> paediatric and adult day surgery<br />
For adult day surgery, current practice is one of no<br />
premedication, a preference <strong>for</strong> induction with propofol<br />
and maintenance with isoflurane. One-tenth<br />
of respondents reported use of propofol <strong>for</strong> maintenance<br />
and one-fifth reported use of sevoflurane.<br />
A very small minority of respondents reported using<br />
desflurane. After induction, fresh gas flow rates are<br />
restricted to around 3 1/min, reflecting moderate<br />
but not ultra-low flow anaesthesia. Laryngeal masks<br />
are used in virtually all patients. Prophylactic antiemetics<br />
were used by approximately half of the<br />
81